These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4779760)

  • 21. Immunogenicity in medical students of current programs for influenza vaccination.
    Berlin BS
    J Am Coll Health Assoc; 1972 Apr; 20(4):241-5. PubMed ID: 5017983
    [No Abstract]   [Full Text] [Related]  

  • 22. [Titration of the serum hemagglutino-inhibiting antibodies against influenza viruses A-FM1, A-Singapore-57, B-Bon-43, B-Roma-62, B-Singapore-64 in a group of subjects from Accra (Ghana)].
    Russo V; Rosei L; D'Arrigo C
    Arch Ital Sci Med Trop Parassitol; 1968; 49(3):77-85. PubMed ID: 5715927
    [No Abstract]   [Full Text] [Related]  

  • 23. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antiviral inhibitors and antibodies in the serum of subjects vaccinated against influenza].
    Kazakova VN; Kupriashina LM
    Vopr Virusol; 1971; 16(6):651-5. PubMed ID: 5141610
    [No Abstract]   [Full Text] [Related]  

  • 25. An influenza A/H3 outbreak during the 2004/2005 winter in elderly vaccinated people living in a nursing home.
    Iorio AM; Neri M; Lepri E; Camilloni B; Basileo M; Sigismondi N; Fabiani C; Calzoletti L; Puzelli S; Donatelli I
    Vaccine; 2006 Nov; 24(44-46):6615-9. PubMed ID: 16828941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the epidemiology of influenza. II. Persistence of HI antibody titers after the outbreaks of influenza A and B with respect to the different course of infection.
    Bruj J; Farník J
    Zentralbl Bakteriol Orig; 1970; 213(1):28-35. PubMed ID: 5460457
    [No Abstract]   [Full Text] [Related]  

  • 27. Influenza antibody response following aerosal administration of inactivated virus.
    Waldman RH; Wood SH; Torres EJ; Small PA
    Am J Epidemiol; 1970 Jun; 91(6):574-85. PubMed ID: 5445644
    [No Abstract]   [Full Text] [Related]  

  • 28. Cigarette smoking and hemagglutination inhibition response to influenza after natural disease and immunization.
    Finklea JF; Hasselblad V; Riggan WB; Nelson WC; Hammer DI; Newill VA
    Am Rev Respir Dis; 1971 Sep; 104(3):368-76. PubMed ID: 5098670
    [No Abstract]   [Full Text] [Related]  

  • 29. [Distribution of the antibodies for influenza A-Hong Kong and A-Eq-2 among the aged].
    Satsuta K; Takahashi M; Yoshikawa I; Ota A; Nakahara K
    Nihon Ika Daigaku Zasshi; 1972 Jan; 39(1):18-22. PubMed ID: 5040428
    [No Abstract]   [Full Text] [Related]  

  • 30. Immune response to influenza vaccination in community-dwelling Chinese elderly persons.
    Hui SL; Chu LW; Peiris JS; Chan KH; Chu D; Tsui W
    Vaccine; 2006 Jun; 24(25):5371-80. PubMed ID: 16713661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza vaccination of patients with systemic lupus erythematosus.
    Mercado U; Acosta H; Avendaño L
    Rev Invest Clin; 2004; 56(1):16-20. PubMed ID: 15144037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preventive influenza vaccination for 2 years in an industrial plant].
    Link F; Schindler M; Majer M
    Pathol Microbiol (Basel); 1970; 36(5):281. PubMed ID: 5513569
    [No Abstract]   [Full Text] [Related]  

  • 33. Measles vaccination. Serologic response and persistence of antibody titer by age at vaccination.
    Biberi-Moroeanu S; Munţiu A; Tiţeica M
    Arch Roum Pathol Exp Microbiol; 1982; 41(4):347-55. PubMed ID: 7171306
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of influenza vaccination in adult liver transplant recipients.
    Soesman NM; Rimmelzwaan GF; Nieuwkoop NJ; Beyer WE; Tilanus HW; Kemmeren MH; Metselaar HJ; de Man RA; Osterhaus AD
    J Med Virol; 2000 May; 61(1):85-93. PubMed ID: 10745238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma.
    Brydak LB; Machała M; Centkowski P; Warzocha K; Biliński P
    Vaccine; 2006 Nov; 24(44-46):6620-3. PubMed ID: 16870313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 38. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season.
    Pyhälä R; Ikonen N; Santanen R; Haanpää M; Visakorpi R; Jäppinen P; Valle M
    J Med Virol; 2001 Nov; 65(3):584-9. PubMed ID: 11596097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeks.
    Buxton JA; Skowronski DM; Ng H; Marion SA; Li Y; King A; Hockin J
    J Infect Dis; 2001 Jul; 184(2):188-91. PubMed ID: 11424016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
    Wesley RD; Lager KM
    Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.